BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6651878)

  • 1. Differential effect of benserazide on catecholamine concentrations in the rat pineal, cerebral cortex and hypothalamus.
    Ho AK; Smith JA
    Biochem Pharmacol; 1983 Dec; 32(23):3605-9. PubMed ID: 6651878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of benserazide (Ro4-4602) on the concentration of indoleamines in rat pineal and hypothalamus.
    Arendt J; Ho AK; Laud C; Marston A; Nohria V; Smith JA; Symons AM
    Br J Pharmacol; 1981 Feb; 72(2):257-62. PubMed ID: 7214095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of benserazide on the levels of pineal 5-hydroxytryptamine, melatonin synthesising enzymes and serum melatonin.
    Ho AK; Smith JA
    Biochem Pharmacol; 1982 Jul; 31(13):2251-5. PubMed ID: 6889864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a high dose of benserazide on the concentrations of 5-hydroxytryptamine, noradrenaline and dopamine in different regions of the rat brain.
    Vellucci SV
    Gen Pharmacol; 1978; 9(6):451-3. PubMed ID: 153258
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of beta-endorphin on catecholamine levels in the rat hypothalamus and cerebral cortex].
    Slavnov VN; Valueva GV; Markov VV; Luchitskiĭ EV
    Biull Eksp Biol Med; 1986 May; 101(5):562-4. PubMed ID: 2939890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24-Hour changes in catecholamine synthesis in rat and hamster pineal glands.
    Craft CM; Morgan WW; Reiter RJ
    Neuroendocrinology; 1984 Mar; 38(3):193-8. PubMed ID: 6144062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of L-dopa and an inhibitor of peripheral decarboxylation on glucose metabolism in brain.
    Tyce GM
    J Neurochem; 1976 Dec; 27(6):1397-403. PubMed ID: 1003214
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypothalamic monoamines and pineal dopamine during the sexual differentiation of the rat brain.
    Hyyppä M
    Experientia; 1971 Mar; 27(3):336-7. PubMed ID: 5546666
    [No Abstract]   [Full Text] [Related]  

  • 9. Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge.
    Masana MI; Heyes MP; Mefford IN
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):609-21. PubMed ID: 2236587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of tetrahydropapaveroline with inhibition of dopa-decarboxylase by Ro 4-4602 in brain: effects on alcohol drinking in the rat.
    Miñano FJ; McMillen BA; Myers RD
    Alcohol; 1989; 6(2):133-7. PubMed ID: 2713086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic protein ingestion on tyrosine and tryptophan levels and catecholamine and serotonin synthesis in rat brain.
    Choi S; DiSilvio B; Fernstrom MH; Fernstrom JD
    Nutr Neurosci; 2011 Nov; 14(6):260-7. PubMed ID: 22053757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protriptyline induced inhibition of the in vivo 3H-noradrenaline synthesis from 3H-L-dopa in the rat brain.
    Nielsen M; Eplov L; Scheel-Krüger J
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):15-28. PubMed ID: 4280017
    [No Abstract]   [Full Text] [Related]  

  • 13. Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK; Sonninen V
    Arch Neurol; 1973 Feb; 28(2):107-10. PubMed ID: 4683147
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of morphine administration on catecholamine levels in rat brain; specific reduction of epinephrine concentration in hypothalamus.
    Ota M; Mefford IN; Naoi M; Linnoila M
    Neurosci Lett; 1991 Jan; 121(1-2):129-32. PubMed ID: 2020369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of brain dopa-decarboxylase by RO 4-4602 infused ICV blocks alcohol drinking induced in rats by cyanamide.
    Miñano FJ; Myers RD
    Psychopharmacology (Berl); 1989; 98(2):176-82. PubMed ID: 2502790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in brain catecholamine levels following DL-dopa are not potentiated by deuterium substitution.
    Dewar KM; Dyck LE; Durden DA; Boulton AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):675-80. PubMed ID: 3937178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The action L-dopa on sexual behaviour of male rats.
    Da Prada M; Carruba M; Saner A; O'Brien A; Pletscher A
    Brain Res; 1973 Jun; 55(2):383-9. PubMed ID: 4541349
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of serum melatonin concentration and synthesis of brain indolealkylamines by monofluoromethyldopa in the rat.
    Bradbury AJ; Giddins RE; Smith JA
    J Pineal Res; 1985; 2(2):169-76. PubMed ID: 2420961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1973 Jan; 10(1):9-12. PubMed ID: 4540511
    [No Abstract]   [Full Text] [Related]  

  • 20. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
    Jonkers N; Sarre S; Ebinger G; Michotte Y
    J Neural Transm (Vienna); 2001; 108(5):559-70. PubMed ID: 11459076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.